Abstract
In vitro studies on dosage mortality response of Helicoverpa armigera (Hub.) to different commercial formulations of HaNPV showed the lowest LC50 value (3.12 X 104 POBs per ml) for BPMS formulation, which indicated its higher virulence compared to other formulations. The HaNPV of PCI, MBP and ZARS-G were on par with each other with 9.5X105, 9.4X105, 15.6X105 POBs per ml and highest LC50 value was recorded with HaNPV formulations of PDBC (11.42X106 POBs/ml).
Cite
CITATION STYLE
M, S., C.S., J. B., C.N., A., & G, G. (2008). LABORATORY EVALUATION OF AVAILABLE COMMERCIAL FORMULATIONS OF HANPV AGAINST HELICOVERPA ARMIGERA (HUB.). Journal of Biopesticides, 1(2), 138–139. https://doi.org/10.57182/jbiopestic.1.2.138-139
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
